In clear cell renal cell carcinoma, the complex of IGF2BP3/lncRNA DMDRMR selectively interacts with their m6A-modified co-targets (including CDK4, COL6A1, LAMA5, and FN1) to promote cell proliferation [61]. This evidence concerns the gene CDK4 and clear cell renal carcinoma.